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Abstract A series of mono-alkylcarboxylic acid deriva-
tives of tetraphenylporphyrin have been prepared. All the
porphyrins were completely characterized by use of mass,
1H NMR, UV–visible, and fluorescence spectroscopy.
Experimental log P were determined by use of reversed-
phase thin-layer chromatography with use of log PRekker.
These porphyrins are potential photosensitizers in photo-
dynamic therapy.
Keywords Porphyrins  Sensitizers  Hydrophobicity 
Fluorescence spectroscopy
Introduction
Hematoporphyrin (1), the first compound that was tried in
photodynamic therapy (PDT), contains, besides the basic
porphyrin ring, two carboxyethylene groups. Photofrin,
currently the most frequently used porphyrin-type com-
pound in anticancer therapy, was obtained from
hematoporphyrin (1) (Fig. 1) [1]. Photofrin molecules
contain carboxyl (carboxyethylene) groups which give the
compound its hydrophobic and hydrophilic properties.
Photofrin preparations are, however, a mixture of several
porphyrin compounds. Numerous research teams around
the world have been trying to obtain novel compounds with
precisely determined structure and controlled biological
properties [2–4]. Several of these compounds are deriva-
tives of tetraphenylporphyrin (2) (tetraarylporphyrin,
Fig. 1). The aryl fragments in these porphyrins are modi-
fied by substituting hydrogen atoms with various groups
altering the hydrophobic–hydrophilic character of the
whole molecule, most often without changing its photo-
chemical properties.
Simple tetraarylporphyrins are highly soluble in slightly
polar solvents, most often halogenated or DMF; these
however cannot be used in biological investigations except
at the stage of preparing photosensitizer–carrier systems,
e.g. liposomes. Most synthetic porphyrins are not very
soluble in simple alcohols. Some porphyrins are soluble in
water which makes them suitable for basic biological
studies. Introduction of strongly polar groups, for example
ammonium or sulfone groups, enables dissolution of tet-
raarylporphyrins in water. Suitably modified porphyrins
can be incorporated into lipid membranes, micelles, or
liposomes; in this form they are delivered into cells [5–13].
Porphyrin carriers of this type are very promising, because
most of the porphyrins obtained synthetically are strongly
hydrophobic which makes them useless in investigations of
direct PDT or other therapeutic applications. Derivatives
with acidic moieties at the ends of alkyl chains have not yet
been studied for their applicability in photodynamic ther-
apy. Compounds with alkyl chains of different lengths
separating the porphyrin fragment from the carboxyl group
were chosen for study. Hydrophobic–hydrophilic character
is responsible for a variety of the properties of organic
compounds, for example solubility, permeability through
semi-permeable membranes (for example cell membranes),
and ability to anchor in lipid layers. Most importantly, for
PDD and PDT it is responsible for the manner of transport
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of photosensitizer molecules into the living organism. The
easiest way to verify the assumed properties of a compound
is by synthesis of the compound.
In search of novel potential photosensitizers we obtained
a series of carboxyalkyloxy tetraphenylporphyrin deriva-
tives 4–8 (Fig. 2). Carboxyl groups are attached to one of
the phenyl rings of tetraphenylporphyrin via alkyl chains of
different lengths. Previously, compounds with n = 1 and
n = 3 were obtained as intermediates during the synthesis
of more complex tetraphenylporphyrin derivatives. In
particular, cholesterol derivatives of carboxymethylporph-
yrin (n = 1) were synthesized and their gelator properties
described [14]. Butyric acid (n = 3) was attached to aryl-
porphyrin via an ether bond in order to obtain a porphyrin
with an easily modifiable fragment (in this case a COOH
group). Next, it was substituted using either lipophilic
guanosine in order to examine the self-assembly of this
group [15] or with a tyrosine group when obtaining mod-
ified TiO2 clusters in which photoinduced electron transfer
occurred [16]. Amide derivatives of this compound were
also obtained as potential agents for photodynamic therapy
of cancers [17]. Glycosidic porphyrins obtained from the
butyric acid derivative of tritolylphenylporphyrin were also
designed as potential PDT agents [18].
Results and discussion
To the best of our knowledge no derivatives with carboxyl
groups at the distal ends of alkyl chains have been investi-
gated for their usefulness in PDT. We thus decided to
investigate compounds with alkyl chains of different lengths
separating the porphyrin fragment from the carboxyl group.
To synthesize alkyl precursors with n = 4, 5, 6, 7, and 11 we
used the classic method of obtaining carboxyl derivatives
starting from suitable dibromoalkyl derivatives and malonic
acid diethyl ester [19, 20]. The yields of the obtained diethyl
(bromoalkyl)malonates were not very high but this could be
expected, especially for shorter alkyl chains. These com-
pounds quite easily undergo intramolecular cyclization
reaction under the reaction conditions [21, 22]. Hydroxy-
phenyltritolylporphyrin (3) was obtained according to Ref.
[23]. Diethyl (x-bromoalkyl)malonates were coupled to a
hydroxyl fragment of porphyrin using NaOH in DMF
(Scheme 1). Under the reaction conditions the monocarboxy
derivatives were obtained directly; in the presence of NaOH
hydrolysis of the ester took place, whereas DMF distillation
at an elevated temperature led to simultaneous decarboxyl-
ation of the malonic acid derivative. Exceptional for this
synthetic route were the reactions of diethyl (3-bromopro-
pyl)malonate leading to a malonic acid derivative and of
diethyl (4-bromobutyl)malonate which gave a pentyloxy
derivative of tetraphenylporphyrin. The properties of the
obtained derivative were compared with those of the similar
compound obtained by direct alkylation of the hydroxy-
phenyl derivative of porphyrin with 1-bromopentane.
Porphyrins 4 and 5 were obtained by a different method,
direct reaction of a suitable ethyl ester of x-bromoalkyl
acid with hydroxyl derivative of porphyrin (Scheme 2).
The esters were hydrolysed to the corresponding carboxylic
derivatives.
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Fig. 2 Synthesized compounds
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All of the obtained porphyrins 4–8 had characteristic
common bands in the visible part of the UV–visible
spectrum. They have very strong absorption peaks centred
at 422 nm (Soret band) and four other peaks centred at 519,
555, 594, and 650 nm (Q bands). The spectra clearly
identify the porphyrinic chromophores of compounds 4–8.
The minor differences between the absorption maxima of
the porphyrins implied their photosensitizing properties are
also comparable. UV–visible data for all the compounds
are listed in Table 1.
Fluorescence spectra of all porphyrins and TPP as a
reference are similar in shape, and consist of two bands at
654 and 720 nm. From Table 2 we can see that the quan-
tum yields of all the porphyrins are almost identical with
that of the reference (TPP). The photostability of com-
pounds 4–9, 11, and 12 was determined for their
chloroform solutions at 25 C. The results presented in
Table 3 show good photostability of the compounds which
indicates their potential usefulness for PDT.
Mass spectrometric analysis of all the synthesized por-
phyrins was performed by use of the ESI–MS technique.
The mass spectra (positive mode) of all the porphyrins
contained a base peak corresponding to the intact porphy-
rin—no fragment ions were detected. For porphyrins 6–8
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and 10 the most intense ions appeared when sodium cations
were present in the solutions.
Lipophilicity is an important molecular descriptor very
often correlated with the biological activity of drugs and
other compounds. It is characterized, for example, by the
logarithm of a partition coefficient (log P). We determined
log P values of all the compounds by a TLC method.
Table 2 shows values calculated by use of the logPRekker
method and the experimental log P values. Log Pexp was
calculated by use of the equation [24]:
log Pexp ¼ log PRekker
2ðRF1 þ RF2Þ
where RF1 and RF2 are retardation factors for methanol–
chloroform 8:2 and 7:3 (v/v), respectively, as mobile phase.
Log PRekker was calculated, in compliance with the
constant fragmentations method proposed by Rekker, by
use of the equation [25, 26]:
log PRekker ¼
Xn
1
anfn
where f is a constant representing the lipophilicity of a
defined structural fragment and a describes how many times
a specific fragment is repeated in a molecule. Experimental
results show that additional methylene units in the carbon
chain result in an increase of the compound’s lipophilicity.
We obtained log Pexp = 1.49 for tetrakis(3-hydroxy-
phenyl)porphyrin as reference compound. The literature
shake-flask log P value for this compound is 2.02 [27].
Solubility in polar solvents is a serious obstacle for the
synthesized compounds. As could be expected, elongation
of the alkyl chain led to increased hydrophobicity of the
whole molecule. As a result, this often leads to aggregation
and precipitation of porphyrins from solutions used for
biological investigations. Currently, all these compounds
are undergoing biological investigation using liposomal
formulations which can substantially reduce the extent of
photosensitizer aggregation and can be valuable carriers
and delivery systems.
Conclusions
Novel mono-carboxyalkyloxyphenyl derivatives of por-
phyrin were synthesized and their physicochemical
properties were examined. Quantum yields of all the
obtained porphyrins are almost identical with that of the
reference compound (TPP). Information about the lipo-
philicity of the examined compounds can prove helpful in
further research on their potential medical uses. Their
balanced hydrophobic–hydrophilic properties make it
Table 1 UV–visible spectra of
compounds 4–9, 11, and 12
[k(log e)] in dichloromethane
solution
Derivative Soret/nm QIV/nm QIII/nm QII/nm QI/nm
4 422 (5.38) 517 (3.95) 554 (3.77) 592 (3.51) 650 (3.63)
5 422 (5.54) 518 (4.04) 555 (3.84) 592 (3.57) 651 (3.58)
6 422 (5.57) 519 (4.10) 555 (3.86) 594 (3.60) 650 (3.58)
7 422 (5.58) 519 (4.17) 555 (3.94) 594 (3.67) 650 (3.66)
8 422 (5.57) 519 (4.13) 555 (3.90) 594 (3.63) 650 (3.67)
9 422 (5.70) 519 (4.30) 554 (4.07) 593 (3.81) 649 (3.77)
11 422 (5.46) 518 (4.05) 555 (4.05) 594 (3.55) 650 (3.52)
12 422 (5.11) 517 (3.67) 554 (3.47) 594 (3.21) 651 (3.31)
Table 2 Fluorescence emission maxima, wavelengths (kmax), and
fluorescence quantum yields (UF) for compounds 4–9 and 11 and
tetraphenylporphyrin (TPP) as reference; log PRekker and log Pexp for
compounds 5–9 and 11
Photosensitizer kmax1/nm kmax2/nm UF log PRekker log Pexp
4 653 720 0.11 – –
5 652 718 0.11 9.08 8.25
6 654 719 0.13 9.60 10.79
7 654 721 0.11 10.12 12.05
8 654 720 0.11 12.19 18.48
9 654 720 0.11 9.39 8.85
11 654 720 0.11 9.55 8.92
TPP 652 718 0.1 – –
Table 3 Photostability of compounds 4–9, 11, and 12
Photosensitizer 0 15 30 45 60 75 90
4 100 99 99 98 97 97 95
5 100 99 96 96 95 95 95
6 100 100 99 99 97 96 96
7 100 100 99 98 98 97 97
8 100 99 98 99 96 95 95
9 100 98 98 97 96 96 96
11 100 99 99 98 97 97 95
12 100 100 98 97 96 96 96
For irradiation, visible light from two 36-W fluorescent lamps was
used and the light intensity was adjusted to 16.5 W/m2. Photostability
was determined by monitoring the intensity of the Soret band after a
defined irradiation time (0–90 min)
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possible to place them in systems (e.g. micelles, liposomes)
similar to natural biological membranes.
Experimental
All chemical reagents were purchased from Aldrich or
Acros and were used without further purification. 1H NMR
and 13C NMR spectra were recorded in CDCl3 using a
Varian spectrometer (400 MHz) with TMS as reference.
UV–visible spectra were recorded in dichloromethane
solutions using a Genesys 6 (ThermoSpectronic) spectro-
photometer. Fluorescence spectra of the samples were
recorded on a Varian Eclipse Cary-fluorescence spectro-
photometer. ESI MS spectra were acquired using an LCQ
DUO Finnigan Thermoquest or a Varian MS-500 instru-
ment. Porphyrin solutions were directly injected into the
ion source by use of a syringe pump.
General procedure for diethyl
(x-bromoalkyl)malonates
Diethyl malonate (0.05 mol), 1,x-dibromoalkane (0.05 mol),
0.375 g tetrabutylammonium iodide (1 mmol), and 15 cm3
toluene were placed in a flask. A solution of 17.25 g K2CO3 in
15 cm3 water was added. The obtained mixture was stirred
and heated to reflux for 20 h. After cooling to room temper-
ature the solid was removed by suction. The organic phase was
separated and the aqueous phase was extracted with toluene
(3 9 10 cm3). The combined organic layers were washed
with water and dried over anhydrous magnesium sulfate. After
evaporating the solvent the product was distilled under
reduced pressure.
Diethyl (3-bromopropyl)malonate
Yield 16%; b.p.: 140–145 C (7–8 mbar), lit. 135 C
(4 mbar) [28], 121–123 C (2 mbar) [19].
Diethyl (4-bromobutyl)malonate
Yield 16%; b.p.: 104–106 C (3–4 mbar), lit. 133–136 C
(2 mbar) [29].
Diethyl (5-bromopentyl)malonate
Yield 21%; b.p.: 178–180 C (8 mbar), lit. 153 C
(3 mbar) [30]; 159–161 C (3 mbar) [31].
Diethyl (6-bromohexyl)malonate
Yield 17%; b.p.: 175–178 C (9 mbar), lit. 185–187C
(10 mbar) [32]; 193 C (12 mbar) [31].
Diethyl (10-bromodecyl)malonate
Yield 20%; b.p.: 222–224 C (7–8 mbar), lit. 123 C
(0.02 mbar) [20, 33].
General procedure for 5-[4-(carboxyalkyloxy)phenyl]-
10,15,20-tritolylporphyrins
5-(4-Hydroxyphenyl)-10,15,20-tritolylporphyrin
(0.24 mmol), solid NaOH (0.8 mmol), and 20 cm3 DMF
were placed in a round-bottomed flask. The mixture was
stirred at room temperature until NaOH was dissolved.
Then 2 mmol diethyl (x-bromoalkyl)malonate were added
and the resulting mixture was stirred at room temperature
for 24 h. After evaporation of the DMF under reduced
pressure 50 cm3 dichloromethane was added to the residue.
The resulting solution was washed with water
(5 9 50 cm3) and dried over MgSO4. After evaporation of
the solvent the crude product was washed with petroleum
ether (20 cm3) and chromatographed on silica with
dichloromethane.
5-[4-(5-Carboxypentyloxy)phenyl]-10,15,20-
tritolylporphyrin (5, C53H46N4O3)
Yield 14%; 1H NMR (400 MHz, CDCl3): d = 8.86 (m,
8H), 8.10 (d, 2H, J = 8.4 Hz), 8.09 (d, 6H, J = 8.0 Hz),
7.54 (d, 6H, J = 8.0 Hz), 7.25 (d, 2H, J = 8.4 Hz), 4.24 (t,
2H), 2.70 (s, 9H), 2.51 (t, 2H), 2.01 (q, 2H), 1.86 (q, 2H),
1.72 (q, 2H), -2.76 (bs, 2H) ppm; ESI–MS: m/z = 787
(100) [M ? H]?.
5-[4-(6-Carboxyhexyloxy)phenyl]-10,15,20-
tritolylporphyrin (6, C54H48N4O3)
Yield 57%; 1H NMR (400 MHz, CDCl3): d = 8.86 (m,
8H), 8.11 (d, 2H, J = 8.4 Hz), 8.10 (d, 6H, J = 8.0 Hz),
7.55 (d, 6H, J = 8.0 Hz), 7.27 (d, 2H, J = 8.4 Hz), 4.27
(t, 2H), 3.55 (t, 2H), 2.71 (s, 9H), 2.10–2.00 (m, 4H), 1.77
(q, 2H), 1.53 (q, 2H), –2.76 (bs, 2H) ppm; ESI–MS:
m/z = 823 (100) [M ? Na]?.
5-[4-(7-Carboxyheptyloxy)phenyl]-
10,15,20-tritolylporphyrin (7, C55H50N4O3)
Yield 14%; 1H NMR (400 MHz, CDCl3): d = 8.85 (m,
8H), 8.10 (d, 2H, J = 8.4 Hz), 8.09 (d, 6H, J = 8.0 Hz),
7.54 (d, 6H, J = 8.0 Hz), 7.27 (d, 2H, J = 8.4 Hz), 4.24 (t,
2H), 3.50 (t, 2H), 2.70 (s, 9H), 1.99 (q, 4H), 1.66 (q, 4H),
1.52 (m, 2H), -2.76 (bs, 2H) ppm; ESI–MS: m/z = 837
(100) [M ? Na]?.
5-[4-(11-Carboxyundecyloxy)phenyl]-10,15,20-
tritolylporphyrin (8, C59H58N4O3)
Yield 18%; 1H NMR (400 MHz, CDCl3): d = 8.85 (m,
8H), 8.10 (d, 2H, J = 8.4 Hz), 8.09 (d, 6H, J = 8.0 Hz),
7.55 (d, 6H, J = 8.0 Hz), 7.27 (d, 2H, J = 8.4 Hz), 4.25 (t,
2H), 3.43 (t, 2H), 2.70 (s, 9H), 2.00 (q, 2H), 1.90 (q, 2H),
1.62 (q, 2H), 1.53–1.20 (m, 12H), -2.76 (bs, 2H) ppm;
ESI–MS: m/z = 894 (100) [M ? Na]?.
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5-[4-[4,4-Bis(ethoxycarbonyl)butyloxy]phenyl]-
10,15,20-tritolylporphyrin (9, C57H52N4O5)
Yield 27%; 1H NMR (400 MHz, CDCl3): d = 8.84 (m,
8H), 8.10 (d, 2H, J = 8.4 Hz), 8.09 (d, 6H, J = 7.6 Hz),
7.54 (d, 6H, J = 7.6 Hz), 7.24 (d, 2H, J = 8.4 Hz), 4.27
(q, 4H), 3.56 (t, 1H), 2.69 (s, 9H), 2.27 (q, 2H), 2.04
(q, 2H), 1.51 (bs, 2H), 1.33 (t, 6H), -2.76 (bs, 2H) ppm;
ESI–MS: m/z = 873 (100) [M ? H]?.
5-(4-Pentyloxyphenyl)-10,15,20-tritolylporphyrin
(10, C52H46N4O)
Yield 14%; 1H NMR (400 MHz, CDCl3): d = 8.87 (m,
8H), 8.11 (d, 2H, J = 8.4 Hz), 8.10 (d, 6H, J = 8.0 Hz),
7.55 (d, 6H, J = 8.0 Hz), 7.27 (d, 2H, J = 8.4 Hz), 4.23 (t,
2H), 2.71 (s, 9H), 1.99 (q, 2H), 1.62 (q, 2H), 1.53 (q, 2H),
1.05 (t, 3H), -2.73 (bs, 2H) ppm; ESI–MS: m/z = 765
(100) [M ? Na]?, 743 (100) [M ? H]?; UV–Vis
(CH2Cl2): kmax (log e) = 422 (5.54), 519 (4.13), 555
(3.89), 593 (3.63), 650 (3.60) nm.
General procedure for 5-[4-[x-(ethoxycarbonyl)-
alkyloxy]phenyl]-10,15,20-tritolylporphyrins
5-(4-Hydroxyphenyl)-10,15,20-tritolylporphyrin (100 mg,
0.15 mmol), 5 mg NaH (0.2 mmol), and 50 cm3 DMF
were placed in a round-bottomed flask and stirred at room
temperature for 30 min. Then 1 mmol ethyl x-bro-
moalkylcarboxylate was added and the resulting mixture
was stirred at 80 C for 48 h. After evaporation of the
DMF under reduced pressure 50 cm3 dichloromethane was
added to the residue. The resulting solution was washed
with water (3 9 50 cm3) and dried over MgSO4. After
evaporation of the solvent the crude product was washed
with petroleum ether (20 cm3) and chromatographed on
silica with dichloromethane–ethanol 30:1 (v/v).
5-[4-[4-(Ethoxycarbonyl)butyloxy]phenyl]-10,15,20-
tritolylporphyrin (11, C54H48N4O3)
Yield 33%; 1H NMR (400 MHz, CDCl3): d = 8.85 (m,
8H), 8.11 (d, 2H, J = 8.0 Hz), 8.09 (d, 6H, J = 7.6 Hz),
7.55 (d, 6H, J = 7.6 Hz), 7.27 (d, 2H, J = 8.0 Hz), 4.28 (t,
2H), 4.21 (q, 2H), 2.71 (s, 9H), 2.52 (q, 2H), 2.03 (m, 4H),
1.33 (t, 3H), -2.76 (bs, 2H) ppm; 13C NMR (125 MHz,
CDCl3): d = 173.19, 155.75, 139.33, 137.32, 135.68,
134.57, 134.53, 130.89, 127.42, 120.09, 120.05, 113.67,
60.44, 33.36, 33.03, 32.04, 23.55, 21.53, 14.26 ppm;
ESI–MS: m/z = 801 (100) [M ? H]?.
5-[4-[5-(Ethoxycarbonyl)pentyloxy]phenyl]-10,15,20-
tritolylporphyrin (12, C55H50N4O3)
Yield 29%; 1H NMR (400 MHz, CDCl3): d = 8.85 (m,
8H), 8.11 (d, 2H, J = 8.0 Hz), 8.10 (d, 6H, J = 7.6 Hz),
7.55 (d, 6H, J = 7.6 Hz), 7.27 (d, 2H, J = 8.0 Hz), 4.26
(t, 2H), 4.19 (q, 2H), 2.71 (s, 9H), 2.44 (t, 2H), 2.01 (q, 2H),
1.84 (q, 2H), 1.69 (q, 2H), 1.31 (t, 3H), -2.76 (bs, 2H) ppm;
13C NMR (125 MHz, CDCl3): d = 173.75, 158.89, 139.36,
137.32, 135.61, 134.54, 129.60, 129.07, 127.43, 120.10,
112.72, 67.98, 60.35, 34.40, 29.23, 25.90, 24.90, 21.55,
14.35 ppm; ESI–MS: m/z = 815 (100) [M ? H]?.
General procedure for 5-(4-carboxyalkyloxyphenyl)-
10,15,20-tritolylporphyrins from ethyl ester
5-[4-(x-Ethoxycarbonylalkyloxy)phenyl]-10,15,20-tritolyl-
porphyrin (0.03 g, *0.04 mmol) dissolved in 10 cm3
dichloromethane was added to a solution of sodium eth-
oxide (1 g sodium dissolved in 10 cm3 ethanol). One drop
of water was added to the mixture. The reaction mixture
was stirred for 3 h at room temperature. The solution was
then acidified to pH 7 with 1 M HCl, washed with water
(3 9 30 cm3), dried over Na2SO4, and concentrated.
Purification by column chromatography on silica gel (elu-
tion with CH2Cl2–EtOH, 25:1 (v/v) afforded the product.
5-[4-(4-Carboxybutyloxy)phenyl]-10,15,20-
tritolylporphyrin (4, C52H44N4O3)
Yield 24%; 1H NMR (400 MHz, CDCl3): d = 8.85 (d,
8H), 8.09 (d, 8H, J = 8.0 Hz), 7.54 (d, 6H, J = 8.0 Hz),
7.24 (d, 2H, J = 8.0 Hz), 4.26 (t, 2H), 2.76 (s, 9H), 2.59
(q, 2H), 2.03 (q, 2H), 1.62 (m, 2H), -2.76 (bs, 2H) ppm;
ESI–MS: m/z = 773 (100) [M ? H]?.
5-[4-(5-Carboxypentyloxy)phenyl]-10,15,20-tritolylpor-
phyrin (5) was obtained by this method in 19% yield.
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